Cells were grown for 20 h before incubation in assay buffer (HBSS supplemented with 10 mM HEPES, 0.1% BSA or 0.1% casein, pH 7.4) for 30 min at 37 C
Santo MA, Riccioppo D, Pajecki D, Kawamoto F, de Cleva R, Antonangelo L, et al
Cohance Lifesciences (Suven Platform): Expanding into niche areas like oligonucleotides and antibody-drug conjugates (ADCs)
IGF-1 LR3 is not approved for therapeutic use in humans and is intended strictly for research purposes
BPC-157 is investigational, not FDA-approved, and banned by WADA
Furthermore, many GLP-1 analog drugs undergo modifications in their structure